Charles Explorer logo
🇨🇿

Response and correction to correspondence on "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component"

Publikace na Lékařská fakulta v Plzni |
2021

Tento text není v aktuálním jazyce dostupný. Zobrazuje se verze "en".Abstrakt

We thank the authors of "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component" for their short correspondence in which they identify an error in Fig. 4 of the original paper [1, 2]. The original sequencing report was reviewed and shows a CTNNB1 c.124A>G (p.Thr41Ala) mutation that was reported incorrectly in the original report.

This was a typographical error in the original report. Review of the sequencing data for case 3 shows this should have indeed been a CTNNB1 c.121A>G (p.Thr41Ala) mutation.

This mistake was unfortunately transcribed and propagated into Table 3 and Fig. 4 and not caught during review of the Table and Figure. Table 3 and Fig. 4 have been revised (see Table 1 and Fig. 1).

The body of the manuscript requires no revisions. The overall study findings remain unchanged.